Prime Capital Investment Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-24,550
Closed -$2.5M 805
2023
Q2
$2.5M Buy
24,550
+18,850
+331% +$1.92M 0.05% 234
2023
Q1
$518K Buy
+5,700
New +$518K 0.02% 338